Muscle Relaxants Flashcards

(30 cards)

1
Q

What is the name of the neurotransmitter at the NMJ of skeletal muscle?

A

Acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is ACh broken down?

A

By acetylcholinesterase - done rapidly, ACh acts for a short duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACh release is blocked by?

A

Magnesium, Aminoglycosides (antibiotics) and Botox.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the different paths in which muscle relaxation can be achieved?

A
  1. Blockade of motor nerves (local anaesthetic) - no downstream electrical activity will occur, therefore sensory and motor loss.
  2. Blockade of NMJ (IV muscle relaxants) - prevent ACh binding to nicotinic receptors,therefore function not performed.
  3. Blockade of receptors inside muscle cells (dantrolene)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name the two types of neuromuscular blockers.

A

Depolarising agents - e.g. suxamethonium

Non-depolarising agents - all other muscle relaxants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Outline the difference in MOA between the different types of neuromuscular blockers.

A

Depolarising - non competitive action, cannot be reversed, wears off or is metabolised over time

Non depolarising - competitive inhibition, competes with ACh for nicotinic receptors and requires reversal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does ED95 mean?

A

Effective dose - dose of muscle relaxant that will paralyse 95% of normal people
Usually intubating dose = 2xED95

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adequate dose of muscle relaxant will result in?

A

Inability to breathe
Inability to maintain airway
Loss of protective reflexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List some factors which potentiate muscle relaxants.

A

Drugs - inhalational agents, amino-glycoside (gentamicin)

Electrolytes - low Ca, high Mg, low K

PH - acidosis

Temperature - cold, warm (with non depolarisers)

Disease - myasthenia gravies, muscular dystrophies, dystonias, myopathies, renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List the indications for muscle relaxation.

A

Surgical factors - facilitate surgical access, immobile field required

Anaesthetic factors - intubation/protection of airway required, controlled ventilation required, prone/abnormal positioning

Patient factors - critical illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Before administering muscle relaxant, it is essential to?

A

Assess the airway
Be competent in airway management
Have necessary equipment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the clinical effects of suxamethonium?

A

Profound paralysis within 60 seconds
Causes fasciculations
Ultra short acting - lasts 5 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain how suxamethonium is excreted.

A

Metabolised by pseudocholinesterase (plasma cholinesterase) which is synthesised in the liver and found freely in plasma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is meant by scoline apnoea and how is it treated?

A

Inherited homozygous/heterozygous conditions which presents with prolonged paralysis due to markedly reduced pseudocholinesterase (faulty enzymes that are unable to break down Sux)

Supportive treatment with ventilation + sedation, give FFP (will contain healthy pseudocholinesterase from donors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List the side effects of suxamethonium.

A

Muscle pains (myalgia)
Bradycardia
Hyerkalaemia and arrhythmias, even cardiac arrest
Triggers malignant hyperthermia
Scoline apnoea
Histamine release
Anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the contraindication for suxamethonium.

A

Drug allergy
Scoline apnoea
MH
Unknown myopathies
Risk of hyperK (renal failure, paralysis, crush/burn injury)

17
Q

Name the two categories of non depolarising agents, and provide example of drugs within each category.

A

Benzylisoquinolines
- atracurium, cisatracurium

Aminosteroids
- pancuronium, vecuronium, rocuronoum

18
Q

Outline the clinical effects of non-depolarisers.

A

Marked paralysis in 1-5 minutes (take longer to act)
No fasciculations
Duration is variable (short, intermediate, long)

19
Q

How are non-depolarisers metabolised and excreted?

A

Metabolism: Hepatic + Hoffman degradation

Excretion: Renal + hepatobiliary

20
Q

Comment on the following things regarding vecuronium:
- duration of action
- physical properties
- impact on CVS
- excretion
- histamine release

A

Intermediate acting

Powder + mixed with water

CVS stable

Hepatobiliary excretion, safe in renal failure but avoid in liver disease

No histamine release

21
Q

Comment on the following things regarding rocuronium:
- duration of action
- impact on CVS

A

Intermediate acting (30 minutes), in higher dose causes longer paralysis but can provide intubation within 1 minutes (rapid sequence induction)

CVS stable

22
Q

Comment on the following things regarding atracurium:
- duration of action
- excretion
- histamine release

A

Intermediate acting

Hoffman degradation (spontaneous degradation, breaks up into inactive molecules), depends on pH and temp, potentially toxic metabolite (laudanosine) can cause convulsion and CNS toxicity, safe in renal + liver failure

Histamine releasing, increased risk of anaphylaxis

23
Q

Comment on the following things regarding cisatracurium:
- duration of action
- physical properties
- excretion
- histamine release

A

Intermediate acting, slower onset of action

Isomer of atracurium

Hoffman degradation, safe in renal failure, no toxic metabolites

No histamine release

24
Q

Explain how the drugs used for reversal of non-depolarising muscle relaxants work.

A

Neostigmine
- acetylcholinesterase inhibitor
- increased ACh concentration in synaptic cleft which competes with NMDR but ACh increase at both nicotinic and muscarinic rectors which can cause side effects

Anticholinergic agent - atropine/glycopyrrolate
- specifically an anti muscarinic agent
- given to prevent muscarinic effects (bronchial secretions, brochospasm, bradycardia, B-eristalis (peristalsis)

25
What will happen if reversal is given to suxamethonium?
Not effective and could even prolong its action
26
When is it safe to reverse?
Check readiness with a peripheral nerve stimulator - at least 3 twitches should be present - if patient already breathing adequately, it is generally safe to administer muscle relaxant
27
With 4 twitches, what percentage of NMJ is still blocked?
75%
28
List the signs of inadequate reversal
Jerky respiration Reduced tidal volume Tracheal tug Restlessness, worsen by hypoxia Inability to raise head from pillow Weak hand grip Poor ability to cough Ptosis
29
How is an inadequate reversal managed?
Exclude another cause - anaesthetic agents, analgesia, hypo or hyper carbia, CVA Maintain ventilation Reverse any potentiators (warm patient, check Mg, K & Ca) Use nerve stimulator Repeat neostigmine (max 5mg) - may cause weakness
30
What is the primary use of sugammadex?
Reverse rocuronium, also works on vecuroium No need to wait like with neostigmine